However, in humans, a loss-of-function allele in ANGPTL3 resulted in a greater decrease in plasma triglyceride levels and a greater decrease in CAD risk relative to carriers of a loss of function allele of ANGPTL4 (12, 15). Here, ANGPTL3 is linked to coronary artery disorder.